Cambridge, Massachusetts-based Biogen Inc. ( BIIB) discovers, develops, manufactures, and delivers therapies for treating ...

Biogen, Inc. is a biopharmaceutical company ... and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Eisai Inc. announced today that screening for Study E2086-A001-101 (Study 101) to assess the efficacy, safety and tolerability of E2086, a novel selective orexin-2 receptor, is now registered on ...

Cambridge Day is raising money and plans to hire a publisher, editor-in-chief, and reporters to expand the organization.

Battery tech is pivotal as the world leans into electrification to power decarbonization in the race against climate change.

Molyon has raised its first round of funding to scale a lithium-sulfur battery that delivers twice the energy density of ...

Sage Therapeutics discontinued development of its lead candidate dalzanemdor after a third clinical failure, leading analysts ...

In this article, we are going to take a look at where Biogen Inc. (NASDAQ:BIIB) stands against the other healthcare stocks. The healthcare industry remains a vital and resilient sector which is ...

The future of a controversial bill that would bar U.S. life sciences companies from working with certain Chinese-owned ...

The two companies have been partnered on Samsung Bioepis for the best part of a decade, successfully bringing six biosimilar copies of biologic drugs to regulatory approval, but Biogen now says it ...